of0
Export
NINDS CDE Notice of Copyright
Scale for Outcomes in Parkinson's Disease-Sleep (SCOPA-Sleep)
Availability
Classification
Supplemental for Huntington's Disease (HD) and Parkinson's Disease (PD).
Short Description of Instrument
Summary/Overview of Instrument: The SCOPA-S (Scale for Outcomes of Parkinson’s disease-Sleep) is a self-rated questionnaire developed originally for research in Parkinson’s disease that addresses both nighttime sleep problems and daytime sleepiness. Its questions focus on experiences over the past month. It has two questions on the use of sleeping medications, one question on an overall global perception of sleep at night, 6 questions on sleep patterns at night and 6 questions on sleep in the day.
 
Construct measured: Two constructs are measured by its two subscales: 1.) Nighttime sleep problems (NS), and 2.) Daytime sleepiness (DS)
 
Generic vs. disease specific: Developed for use in Parkinson’s disease research, but its questions do not refer at all to Parkinson’s disease with the original intent for it to be potentially useful across other conditions. It has been used in one study of Huntington’s disease patients and controls.
Intended use of instrument/purpose of tool: For research or clinical purposes—it could be used as a screening instrument or for rating severity of nighttime sleep disturbances or daytime sleepiness.
 
Means of administration: Paper and Pencil
 
Location of administration: Clinic or home
 
Intended respondent: Patient
 
# of items: 14 (2 questions on use of sleeping tablets, 1 global perception of sleep at night question, and the 11 items of the two subscales
 
# of subscales and names of sub-scales: 2 – Nighttime sleep problems (NS:5 items; score range:0-15), Daytime sleepiness (DS:6 items; score range 0-18)
Scoring
Scoring: With the exception of the one question on use of sleep medications in which the names of medications are listed with doses and frequency of use, all 13 other items are Likert-type, with 4 to seven options such as “not at all,” “a little,” “quite a bit,” and “a lot”. All 11 questions from the two subscales, NS and DS have 4 o ptions which are scored 0-3. S ubscale totals are easily calculated though summing the totals of all items in that subscale.
 
Standardization of scores to a reference population (z scores, T scores, etc): Insufficient research data to convert subscale scores to standardized scores, either with reference to normal population or manifest HD patients, presymptomatic gene carriers or controls.
 
If scores have been standardized to a reference population, indicate frame of reference for scoring (general population, HD subjects, other disease groups, etc). Not available.
Psychometric Properties
Reliability: Test-retest or intra-interview (within rater) reliability (as applicable): not assessed in HD populations, but good test-retest reliability in Parkinson’s disease population (intraclass correlation coefficients for NS 0.94, and DS 0.89 (Marinus et al, 2003) Inter-interview (between-rater) reliability (as applicable): Not assessed in HD populations Internal consistency: Cronbach’s alpha for SCOPA-NS 0.89 and for SCOPA- DS 0.85 in HD sample (Aziz et al.2010); in PD sample these values were 0.88 and 0.91.
 
Validity: Content validity: Not reported in reviewed references Construct validity: found to correlate highly with other scales that measure similar constructs: in HD subjects the NS subscale correlated highly with the Pittsburgh Sleep Quality Index (r=0.77) in a small HD sample (Aziz et al., 2010) and the DS subscale correlated highly with a measure of daytime sleepiness, the Epworth Sleepiness Scale (r=0.75).
 
Diagnostic Sensitivity and Specificity, if applicable (in general population, HD population- premanifest/ manifest, other disease groups): Not appropriate for diagnosis of sleep disorders; rather, it is useful for screening and for measurement of the constructs of nighttime sleep problems and daytime sleepiness
References
Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stieggelbout AM. Assessment of Sleep and Sleepiness in Parkinson Disease. Sleep 2003; 26:1049-54.
 
Other References:
 
Aziz NA, Anguelova GV, Marinus J, Lammers GJ, Roos RAC. Sleep and Circadian rhythm alterations correlate with depression and cognitive impairment in Huntington’s disease. Parkinsonism and Related Disorders 2010;16:345-50.
 
Hogl B, Arnulf I, Comella C, et al. Scales to Assess Sleep Impairment in Parkinson’s Disease:Critique and Recommendations. Movement Disorders 2010;25:2704-16.
Page 1 of 1